Related references
Note: Only part of the references are listed.Effects of human umbilical cord mesenchymal stem cells on co-cultured ovarian carcinoma cells
Xiufeng Li et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2019)
Effect of adipose-derived mesenchymal stem cells on hepatocellular carcinoma: In vitro inhibition of carcinogenesis
Rim Serhal et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer
Rachael Mooney et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
In Vivo Cell Fusion between Mesenchymal Stroma/Stem-Like Cells and Breast Cancer Cells
Catharina Melzer et al.
CANCERS (2019)
Active Fraction from Embryo Fish Extracts Induces Reversion of the Malignant Invasive Phenotype in Breast Cancer through Down-Regulation of TCTP and Modulation of E-cadherin/β-catenin Pathway
Sara Proietti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Overview of CD24 as a new molecular marker in ovarian cancer
Vahideh Tarhriz et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine
Tarini Nawamalie Abeysinghe Gunawardena et al.
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2019)
Corneal Wound Healing Effects of Mesenchymal Stem Cell Secretome Delivered Within a Viscoelastic Gel Carrier
Gabriella Maria Fernandes-Cunha et al.
STEM CELLS TRANSLATIONAL MEDICINE (2019)
Mesenchymal Stem Cell Therapy for Osteoarthritis: The Critical Role of the Cell Secretome
Patrizio Mancuso et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Mesenchymal stem cells transplantation in hematological patients with acute graft-versus-host disease: characteristics and risk factors for infectious complications
Igor Stoma et al.
ANNALS OF HEMATOLOGY (2018)
The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts
Andrea Mohr et al.
CANCER LETTERS (2018)
Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance
Kristina Lindemann et al.
GYNECOLOGIC ONCOLOGY (2018)
Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer
Ernest S. Han et al.
Oncotarget (2018)
Clinical trial in progress: A study of VB-111 combined with paclitaxel vs. paclitaxel for treatment of recurrent platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018).
Richard T. Penson et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Mesenchymal Stem Cell Derived Exosomes in Cancer Progression, Metastasis and Drug Delivery: A Comprehensive Review
Jingyi Zhou et al.
JOURNAL OF CANCER (2018)
The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks
Alaa T. Alshareeda et al.
PLOS ONE (2018)
NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development
Patricia Ahechu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human Wharton's Jelly Stem Cell (hWJSC) Extracts Inhibit Ovarian Cancer Cell Lines OVCAR3 and SKOV3 in vitro by Inducing Cell Cycle Arrest and Apoptosis
Gauthaman Kalamegam et al.
FRONTIERS IN ONCOLOGY (2018)
IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment
Yu-Jie Liu et al.
JOURNAL OF DRUG TARGETING (2017)
Pro- and anti-inflammatory cytokine associations with major depression in cancer patients
Madeline Li et al.
PSYCHO-ONCOLOGY (2017)
Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers
Grazyna Ewa Bedkowska et al.
JOURNAL OF OVARIAN RESEARCH (2017)
Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells
Qin Shi et al.
STEM CELL RESEARCH & THERAPY (2017)
Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth
Padmanaban Guruprasath et al.
BIOMATERIALS (2017)
Effects of matrix metalloproteinases on the fate of mesenchymal stem cells
Sami G. Almalki et al.
STEM CELL RESEARCH & THERAPY (2016)
Mesenchymal Cell Contributions to the Stem Cell Niche
Youmna Kfoury et al.
CELL STEM CELL (2015)
Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125
Brett McKinnon et al.
MOLECULAR MEDICINE REPORTS (2015)
Ovarian cancer: involvement of the matrix metalloproteinases
Linah Al-Alem et al.
REPRODUCTION (2015)
The structural network of Interleukin-10 and its implications in inflammation and cancer
Ece Saliha Acuner-Ozbabacan et al.
BMC GENOMICS (2014)
Lessons from tumor reversion for cancer treatment
Robert Amson et al.
CURRENT OPINION IN ONCOLOGY (2013)
Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: A SEER analysis
J. Alejandro Rauh-Hain et al.
GYNECOLOGIC ONCOLOGY (2013)
Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion
Xiaoxia Hu et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
Takashi Tanikawa et al.
CANCER RESEARCH (2012)
Mesenchymal stem cells from umbilical cord blood: parameters for isolation, characterization and adipogenic differentiation
Tatiana Tais Sibov et al.
CYTOTECHNOLOGY (2012)
NF-κB and the link between inflammation and cancer
Joseph A. DiDonato et al.
IMMUNOLOGICAL REVIEWS (2012)
Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation
Darwin J. Prockop et al.
MOLECULAR THERAPY (2012)
Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC
Ralf Hass et al.
CELL COMMUNICATION AND SIGNALING (2011)
Phase II Evaluation of Paclitaxel and Carboplatin in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study
Matthew A. Powell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model
Xiaoyang Ling et al.
CANCER MICROENVIRONMENT (2010)
Paradoxical Roles of IL-4 in Tumor Immunity
Zhiguang Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2009)
Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages
Jaehyup Kim et al.
EXPERIMENTAL HEMATOLOGY (2009)
MMP-2, MTI-MMP, and TMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines
Christian Ries et al.
BLOOD (2007)
Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group study
Howard D. Homesley et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Current management of ovarian carcinosarcoma
M. S. Mano et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue
Susanne Kern et al.
STEM CELLS (2006)
Translationally controlled tumor protein is a target of tumor reversion
M Tuynder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Carcinosarcoma of the ovary - 19 years of prospective data from a single center
E Brown et al.
CANCER (2004)
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival
G Kristiansen et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Share Paper
